Capital Farma

Capital Farma is a Spanish pharmaceutical company and CDMO specializing in the development, production, and distribution of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs). Headquartered in Madrid, the company is committed to the "re-industrialization" of Europe by reshoring API manufacturing from Asia through co-investments and technology transfers with European manufacturers. Capital Farma manages a diverse portfolio of niche products, including minocycline hydrochloride, and provides comprehensive services such as custom synthesis, biologics development, and supply chain optimization. The company operates a global decentralized model with specialized offices and representatives in Poland, Egypt, Peru, Colombia, and India. By bridging the gap between geographic production zones and consumption areas, Capital Farma serves as a strategic partner for generic laboratories seeking reliable, high-quality pharmaceutical supply chains.